Search research articles
Contact Us
Filters
Showing results (151-160 of 229) with videos related to
Page
of 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2019
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
N Colombo, C Sessa, A du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 4, 2019
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N Colombo, C Sessa, A du Bois, et al.
ESMO Open
|
January 4, 2025
Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers
J-Y Blay, M Brahmi, A Dufresne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
I Vergote, A González-Martín, I Ray-Coquard, et al.
ESMO Open
|
June 5, 2025
Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial
L Collet, J-C Noël, X Catteau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial
B Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
N Penel, A Le Cesne, B N Bui, et al.
Bulletin Du Cancer
|
December 25, 2007
[Surveillance Bulletin 2007. Guidelines for clinical practice: management of patients with malignant epithelial tumors of the ovary. First line medical treatment]
C Lhommé, F Planchamp, F Joly, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 229) with videos related to
Sort By:
Page
of 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2019
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
N Colombo, C Sessa, A du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 4, 2019
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N Colombo, C Sessa, A du Bois, et al.
ESMO Open
|
January 4, 2025
Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers
J-Y Blay, M Brahmi, A Dufresne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
I Vergote, A González-Martín, I Ray-Coquard, et al.
ESMO Open
|
June 5, 2025
Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial
L Collet, J-C Noël, X Catteau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial
B Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
N Penel, A Le Cesne, B N Bui, et al.
Bulletin Du Cancer
|
December 25, 2007
[Surveillance Bulletin 2007. Guidelines for clinical practice: management of patients with malignant epithelial tumors of the ovary. First line medical treatment]
C Lhommé, F Planchamp, F Joly, et al.
Page
of 23